About L2P Research Labs
L2P Research Labs is a company based in Stony Brook (United States) founded in 2015 by Suresh Anaganti was acquired by NJ Bio in November 2025. It operates as a Professional Services. L2P Research Labs offers products and services including Clinical Research and Non-Clinical Research. L2P Research Labs operates in a competitive market with competitors including Redbud Medicine, OncoTheis, AlphaVax, Lukas Biomedical and DXOCRO, among others.
- Headquarter Stony Brook, United States
- Founders Suresh Anaganti
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of L2P Research Labs
L2P Research Labs offers a comprehensive portfolio of products and services, including Clinical Research and Non-Clinical Research.
Clinical research services are provided for medical studies.
Non-clinical research services are offered for preclinical studies.
Funding Insights of L2P Research Labs
Investors in L2P Research Labs
L2P Research Labs has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and NJ Bio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Clinical development services are provided for biotechnology applications.
|
Locked | Locked | Locked |
Investor details for L2P Research Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by L2P Research Labs
Investment portfolio details for L2P Research Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - L2P Research Labs
Detailed financials for L2P Research Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
L2p Research Labs Comparisons
Peer comparison for L2P Research Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of L2P Research Labs
L2P Research Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Redbud Medicine, OncoTheis, AlphaVax, Lukas Biomedical and DXOCRO, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Offers comprehensive services in regulatory affairs, R&D, data management, and statistical analysis for healthcare.
|
|
| Locked | Locked | Locked |
Provides 3D tissue testing services for in-vitro lung cancer drug testing.
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases and cancer immunotherapy are developed.
|
|
| Locked | Locked | Locked |
A biotechnology company developing autologous immune cell therapies to treat various types of cancer.
|
|
| Locked | Locked | Locked |
Provides in vitro diagnostic services for oncology research and development.
|
|
| Locked | Locked | Locked |
Offers tumoroid-based platforms for cancer drug screening and personalized medicine services.
|
Detailed competitors of L2P Research Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on L2p Research Labs
Complete news archive for L2P Research Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about L2P Research Labs
L2P Research Labs was founded in 2015 and raised its 1st funding round 8 years after it was founded.
L2P Research Labs is headquartered in Stony Brook, United States. It is registered at Stony Brook, New York, United States.
Suresh Anaganti is the current CEO of L2P Research Labs. They have also founded this company.
L2P Research Labs is involved in providing clinical and non-clinical research services. The company operates in the healthcare and biotechnology sector, focusing on IND-enabling studies. State-of-the-art instruments are utilized to ensure high-quality data. Robust quality assurance programs are maintained, with GLP-compliant facilities. Solutions are offered to strengthen research outcomes for clients across various projects.
L2P Research Labs's top competitors include Ontogen, AlphaVax and Cancer Research For Oza Rks.
L2P Research Labs offers Clinical Research and Non-Clinical Research.